vs

Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and WIDEPOINT CORP (WYY). Click either name above to swap in a different company.

Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $42.3M, roughly 1.5× WIDEPOINT CORP). WIDEPOINT CORP runs the higher net margin — -2.0% vs -70.9%, a 68.9% gap on every dollar of revenue. On growth, WIDEPOINT CORP posted the faster year-over-year revenue change (12.3% vs 8.1%). WIDEPOINT CORP produced more free cash flow last quarter ($-270.0K vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 11.2%).

Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.

WidePoint Corporation is an American company based in Fairfax, Virginia that provides technology-based products and services to the government sector and commercial markets in the United States. The company holds a patent for a digital parsing tool that allows users to access accounts through a secure repository gateway, established using asymmetric authentication employed as public key infrastructure (PKI). WidePoint provides smart card identity verification, wireless expense management, pen...

CTKB vs WYY — Head-to-Head

Bigger by revenue
CTKB
CTKB
1.5× larger
CTKB
$62.1M
$42.3M
WYY
Growing faster (revenue YoY)
WYY
WYY
+4.1% gap
WYY
12.3%
8.1%
CTKB
Higher net margin
WYY
WYY
68.9% more per $
WYY
-2.0%
-70.9%
CTKB
More free cash flow
WYY
WYY
$1.5M more FCF
WYY
$-270.0K
$-1.8M
CTKB
Faster 2-yr revenue CAGR
CTKB
CTKB
Annualised
CTKB
17.7%
11.2%
WYY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTKB
CTKB
WYY
WYY
Revenue
$62.1M
$42.3M
Net Profit
$-44.1M
$-849.4K
Gross Margin
52.9%
13.8%
Operating Margin
-9.0%
-1.9%
Net Margin
-70.9%
-2.0%
Revenue YoY
8.1%
12.3%
Net Profit YoY
-557.1%
-138.3%
EPS (diluted)
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTKB
CTKB
WYY
WYY
Q4 25
$62.1M
$42.3M
Q3 25
$52.3M
$36.1M
Q2 25
$45.6M
$37.9M
Q1 25
$41.5M
$34.2M
Q4 24
$57.5M
$37.7M
Q3 24
$51.5M
$34.6M
Q2 24
$46.6M
$36.0M
Q1 24
$44.9M
$34.2M
Net Profit
CTKB
CTKB
WYY
WYY
Q4 25
$-44.1M
$-849.4K
Q3 25
$-5.5M
$-559.2K
Q2 25
$-5.6M
$-618.5K
Q1 25
$-11.4M
$-724.1K
Q4 24
$9.6M
$-356.4K
Q3 24
$941.0K
$-425.2K
Q2 24
$-10.4M
$-499.6K
Q1 24
$-6.2M
$-653.1K
Gross Margin
CTKB
CTKB
WYY
WYY
Q4 25
52.9%
13.8%
Q3 25
52.7%
14.6%
Q2 25
52.3%
13.5%
Q1 25
48.6%
14.0%
Q4 24
58.5%
12.6%
Q3 24
56.3%
13.6%
Q2 24
54.6%
13.6%
Q1 24
51.3%
13.6%
Operating Margin
CTKB
CTKB
WYY
WYY
Q4 25
-9.0%
-1.9%
Q3 25
-17.6%
-1.3%
Q2 25
-23.3%
-1.9%
Q1 25
-36.1%
-2.4%
Q4 24
5.2%
-0.8%
Q3 24
-8.2%
-1.3%
Q2 24
-18.3%
-1.3%
Q1 24
-23.9%
-1.9%
Net Margin
CTKB
CTKB
WYY
WYY
Q4 25
-70.9%
-2.0%
Q3 25
-10.5%
-1.5%
Q2 25
-12.2%
-1.6%
Q1 25
-27.5%
-2.1%
Q4 24
16.8%
-0.9%
Q3 24
1.8%
-1.2%
Q2 24
-22.4%
-1.4%
Q1 24
-13.8%
-1.9%
EPS (diluted)
CTKB
CTKB
WYY
WYY
Q4 25
$-0.08
Q3 25
$-0.06
Q2 25
$-0.06
Q1 25
$-0.08
Q4 24
$-0.05
Q3 24
$-0.04
Q2 24
$-0.05
Q1 24
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTKB
CTKB
WYY
WYY
Cash + ST InvestmentsLiquidity on hand
$90.9M
$9.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$341.7M
$11.5M
Total Assets
$461.5M
$79.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTKB
CTKB
WYY
WYY
Q4 25
$90.9M
$9.8M
Q3 25
$93.3M
$12.1M
Q2 25
$75.5M
$6.8M
Q1 25
$95.3M
$3.7M
Q4 24
$98.7M
$6.8M
Q3 24
$162.3M
Q2 24
$177.9M
Q1 24
$168.8M
Stockholders' Equity
CTKB
CTKB
WYY
WYY
Q4 25
$341.7M
$11.5M
Q3 25
$378.6M
$12.2M
Q2 25
$377.6M
$12.6M
Q1 25
$379.6M
$13.0M
Q4 24
$395.7M
$13.6M
Q3 24
$385.5M
$13.8M
Q2 24
$389.1M
$14.0M
Q1 24
$392.6M
$14.2M
Total Assets
CTKB
CTKB
WYY
WYY
Q4 25
$461.5M
$79.8M
Q3 25
$494.9M
$70.6M
Q2 25
$493.3M
$76.6M
Q1 25
$482.6M
$71.4M
Q4 24
$499.5M
$71.6M
Q3 24
$491.2M
$56.9M
Q2 24
$483.7M
$58.6M
Q1 24
$492.1M
$54.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTKB
CTKB
WYY
WYY
Operating Cash FlowLast quarter
$-771.0K
$-173.5K
Free Cash FlowOCF − Capex
$-1.8M
$-270.0K
FCF MarginFCF / Revenue
-2.9%
-0.6%
Capex IntensityCapex / Revenue
1.6%
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-8.8M
$5.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTKB
CTKB
WYY
WYY
Q4 25
$-771.0K
$-173.5K
Q3 25
$-3.9M
$5.9M
Q2 25
$108.0K
$3.2M
Q1 25
$-125.0K
$-3.2M
Q4 24
$2.0M
$2.4M
Q3 24
$13.2M
$1.9M
Q2 24
$6.2M
$-1.1M
Q1 24
$4.0M
$-1.6M
Free Cash Flow
CTKB
CTKB
WYY
WYY
Q4 25
$-1.8M
$-270.0K
Q3 25
$-4.6M
$5.9M
Q2 25
$-1.5M
$3.1M
Q1 25
$-974.0K
$-3.3M
Q4 24
$1.1M
$2.4M
Q3 24
$12.2M
$1.8M
Q2 24
$5.2M
$-1.1M
Q1 24
$3.4M
$-1.6M
FCF Margin
CTKB
CTKB
WYY
WYY
Q4 25
-2.9%
-0.6%
Q3 25
-8.7%
16.4%
Q2 25
-3.2%
8.1%
Q1 25
-2.3%
-9.5%
Q4 24
1.9%
6.4%
Q3 24
23.7%
5.3%
Q2 24
11.0%
-3.0%
Q1 24
7.6%
-4.6%
Capex Intensity
CTKB
CTKB
WYY
WYY
Q4 25
1.6%
0.2%
Q3 25
1.3%
0.1%
Q2 25
3.5%
0.2%
Q1 25
2.0%
0.1%
Q4 24
1.6%
0.1%
Q3 24
2.0%
0.2%
Q2 24
2.3%
0.0%
Q1 24
1.3%
0.0%
Cash Conversion
CTKB
CTKB
WYY
WYY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.21×
Q3 24
14.05×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

WYY
WYY

Carrier Services$26.8M63%
Managed Services$15.5M37%

Related Comparisons